- Platform to predict future AF/atrial flutter nets breakthrough device designation Healio
- FDA Grants Breakthrough Device Designation to Tempus' Atrial Fibrillation ECG Analysis Platform, Developed in Collaboration With Geisinger Business Wire
- View Full coverage on Google News
Platform to predict future AF/atrial flutter nets breakthrough device designation – Healio
ByGoogle News
Mar 25, 2021